Direxion Daily Semicondct Bull 3X ETF

ProShares UltraShort Bloomberg Natrl Gas

VS TR -1x Short VIX Futures ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Daily Technology Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X ETF

Guggenheim Solar ETF

Direxion Daily Financial Bull 3X ETF

Bank Of Montreal

ProShares UltraPro Dow30

VS TR 2x Long VIX Futures ETF

Direxion Daily Semicondct Bear 3X ETF

ProShares Ultra VIX Short-Term Futures

ProShares Ultra Bloomberg Natural Gas

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily S&P Biotech Bear 3X ETF

Direxion Technology Bear 3X Shares

Direxion Financial Bear 3X Shar

Direxion Daily Gold Miners Bull 3X ETF

QuantumScape Corporation Class A Common Stock

Oklo Inc.

Reddit Inc. Class A Common Stock

Uber Technologies Inc. Common Stock

Gray Television Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

Carnival Corporation Common Stock

Ciena Corporation Common Stock

Snap Inc. Class A Common Stock

KKR & Co. Inc. Common Stock

FedEx Corporation Common Stock

AgEagle Aerial Systems Inc. Common Stock

Alamos Gold Inc. Class A Common Shares

Occidental Petroleum Corporation Common Stock

Civitas Resources Inc. Common Stock

Gold Fields Limited American Depositary Shares

Noble Corporation plc A Ordinary Shares

Exxon Mobil Corporation Common Stock

United Microelectronics Corporation (NEW) Common Stock

Raytheon Technologies Corporation Common Stock

Click here to get full coverage on It's Unlikely That The CEO Of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Will See A Huge Pay Rise This Year - simplywall.st

It's Unlikely That The CEO Of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Will See A Huge Pay Rise This Year  simplywall.st

It's Unlikely That The CEO Of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Will See A Huge Pay Rise This Year - simplywall.st

Click here to get full coverage on $VYGR stock is up 24% today. Here's what we see in our data. - Nasdaq

$VYGR stock is up 24% today. Here's what we see in our data.  Nasdaq

$VYGR stock is up 24% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now - Yahoo Finance

Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now  Yahoo Finance

Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now - Yahoo Finance

Click here to get full coverage on Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Stock Titan

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference  Stock Titan

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Stock Titan

Click here to get full coverage on Voyager Therapeutics stock plunges to 52-week low of $2.71 - Investing.com

Voyager Therapeutics stock plunges to 52-week low of $2.71  Investing.com

Voyager Therapeutics stock plunges to 52-week low of $2.71 - Investing.com

Click here to get full coverage on Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance (VYGR) - Seeking Alpha

Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance (VYGR)  Seeking Alpha

Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance (VYGR) - Seeking Alpha

Click here to get full coverage on VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm  PR Newswire

VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

Click here to get full coverage on Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... - Yahoo Finance

Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and ...  Yahoo Finance

Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... - Yahoo Finance

Click here to get full coverage on Voyager Therapeutics Approves Stock Plans at Annual Meeting - TipRanks

Voyager Therapeutics Approves Stock Plans at Annual Meeting  TipRanks

Voyager Therapeutics Approves Stock Plans at Annual Meeting - TipRanks

Click here to get full coverage on Positive Sentiment Still Eludes Voyager Therapeutics, Inc. (NASDAQ:VYGR) Following 27% Share Price Slump - simplywall.st

Positive Sentiment Still Eludes Voyager Therapeutics, Inc. (NASDAQ:VYGR) Following 27% Share Price Slump  simplywall.st

Positive Sentiment Still Eludes Voyager Therapeutics, Inc. (NASDAQ:VYGR) Following 27% Share Price Slump - simplywall.st

Click here to get full coverage on New Alzheimer's Breakthrough: Single-Dose Gene Therapy Slashes Tau Levels by 73% - Stock Titan

New Alzheimer's Breakthrough: Single-Dose Gene Therapy Slashes Tau Levels by 73%  Stock Titan

New Alzheimer's Breakthrough: Single-Dose Gene Therapy Slashes Tau Levels by 73% - Stock Titan

Click here to get full coverage on 7 Analysts Assess Voyager Therapeutics: What You Need To Know - Nasdaq

7 Analysts Assess Voyager Therapeutics: What You Need To Know  Nasdaq

7 Analysts Assess Voyager Therapeutics: What You Need To Know - Nasdaq

Click here to get full coverage on Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade) - Seeking Alpha

Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade)  Seeking Alpha

Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade) - Seeking Alpha

Click here to get full coverage on Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates  Yahoo Finance

Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Institutional investors may adopt severe steps after Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) latest 15% drop adds to a year losses - simplywall.st

Institutional investors may adopt severe steps after Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) latest 15% drop adds to a year losses  simplywall.st

Institutional investors may adopt severe steps after Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) latest 15% drop adds to a year losses - simplywall.st

Click here to get full coverage on Revolutionary Brain Drug Delivery: Voyager's New Gene Therapy Shows 400x Improvement in Landmark Research - Stock Titan

Revolutionary Brain Drug Delivery: Voyager's New Gene Therapy Shows 400x Improvement in Landmark Research  Stock Titan

Revolutionary Brain Drug Delivery: Voyager's New Gene Therapy Shows 400x Improvement in Landmark Research - Stock Titan

Click here to get full coverage on Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance

Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Insiders Sold Voyager Therapeutics Prematurely At US$7.47 With Stock Trading Higher - simplywall.st

Insiders Sold Voyager Therapeutics Prematurely At US$7.47 With Stock Trading Higher  simplywall.st

Insiders Sold Voyager Therapeutics Prematurely At US$7.47 With Stock Trading Higher - simplywall.st

Click here to get full coverage on What Makes Voyager Therapeutics (VYGR) a New Buy Stock - Yahoo Finance

What Makes Voyager Therapeutics (VYGR) a New Buy Stock  Yahoo Finance

What Makes Voyager Therapeutics (VYGR) a New Buy Stock - Yahoo Finance

Click here to get full coverage on Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks  Yahoo Finance

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Click here to get full coverage on Voyager Therapeutics: Q1 Earnings Snapshot - NewsTimes

Voyager Therapeutics: Q1 Earnings Snapshot  NewsTimes

Voyager Therapeutics: Q1 Earnings Snapshot - NewsTimes

Click here to get full coverage on Voyager reports breakthrough in brain drug delivery - Investing.com

Voyager reports breakthrough in brain drug delivery  Investing.com

Voyager reports breakthrough in brain drug delivery - Investing.com

Click here to get full coverage on A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts - Nasdaq

A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts  Nasdaq

A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts - Nasdaq

Click here to get full coverage on Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference  GlobeNewswire

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire

Click here to get full coverage on Voyager Reports First Quarter 2025 Financial and Operating Results - GlobeNewswire

Voyager Reports First Quarter 2025 Financial and Operating Results  GlobeNewswire

Voyager Reports First Quarter 2025 Financial and Operating Results - GlobeNewswire

Click here to get full coverage on Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - GlobeNewswire

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences  GlobeNewswire

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - GlobeNewswire

Click here to get full coverage on Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - GlobeNewswire

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast  GlobeNewswire

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - GlobeNewswire

Click here to get full coverage on Voyager reveals promising Alzheimer’s therapy data - Investing.com

Voyager reveals promising Alzheimer’s therapy data  Investing.com

Voyager reveals promising Alzheimer’s therapy data - Investing.com

Click here to get full coverage on Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected - GlobeNewswire

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected  GlobeNewswire

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected - GlobeNewswire

Click here to get full coverage on Voyager Therapeutics Inc earnings missed by $0.08, revenue fell short of estimates - Investing.com

Voyager Therapeutics Inc earnings missed by $0.08, revenue fell short of estimates  Investing.com

Voyager Therapeutics Inc earnings missed by $0.08, revenue fell short of estimates - Investing.com

Click here to get full coverage on An Investigation Has Commenced on Behalf of Voyager Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your VYGR Losses. - ACCESS Newswire

An Investigation Has Commenced on Behalf of Voyager Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your VYGR Losses.  ACCESS Newswire

An Investigation Has Commenced on Behalf of Voyager Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your VYGR Losses. - ACCESS Newswire

Click here to get full coverage on Top-rated biotechs with negative enterprise values - Seeking Alpha

Top-rated biotechs with negative enterprise values  Seeking Alpha

Top-rated biotechs with negative enterprise values - Seeking Alpha

Click here to get full coverage on VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today - InvestorPlace

VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today  InvestorPlace

VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today - InvestorPlace

Click here to get full coverage on VYGR Stock Price and Chart — NASDAQ:VYGR - TradingView

VYGR Stock Price and Chart — NASDAQ:VYGR  TradingView

VYGR Stock Price and Chart — NASDAQ:VYGR - TradingView

Click here to get full coverage on Vanguard Group Cuts Stake in Voyager Therapeutics (VYGR) - Nasdaq

Vanguard Group Cuts Stake in Voyager Therapeutics (VYGR)  Nasdaq

Vanguard Group Cuts Stake in Voyager Therapeutics (VYGR) - Nasdaq

Click here to get full coverage on Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer - GlobeNewswire

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer  GlobeNewswire

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer - GlobeNewswire

Click here to get full coverage on Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Stock Titan

Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference  Stock Titan

Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Stock Titan

Click here to get full coverage on Media Tech Platform Vygr News elevates Abhishake Das to Co-Founder - Business Standard

Media Tech Platform Vygr News elevates Abhishake Das to Co-Founder  Business Standard

Media Tech Platform Vygr News elevates Abhishake Das to Co-Founder - Business Standard

Click here to get full coverage on Vygr Media Launches the revolutionary PAABA: Building Podcast IPs for Brands as key Business Asset - Business Standard

Vygr Media Launches the revolutionary PAABA: Building Podcast IPs for Brands as key Business Asset  Business Standard

Vygr Media Launches the revolutionary PAABA: Building Podcast IPs for Brands as key Business Asset - Business Standard

Click here to get full coverage on Check out Voyager Therapeutics's stock price (VYGR) in real time - CNBC

Check out Voyager Therapeutics's stock price (VYGR) in real time  CNBC

Check out Voyager Therapeutics's stock price (VYGR) in real time - CNBC

Click here to get full coverage on Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer - GlobeNewswire

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer  GlobeNewswire

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer - GlobeNewswire

Click here to get full coverage on Voyageur Pharmaceuticals takes major step forward announcing International Expansion - Proactive financial news

Voyageur Pharmaceuticals takes major step forward announcing International Expansion  Proactive financial news

Voyageur Pharmaceuticals takes major step forward announcing International Expansion - Proactive financial news

Click here to get full coverage on VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024 - MSN

VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024  MSN

VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024 - MSN

Click here to get full coverage on Voyager Therapeutics (VYGR) Stock Price, News & Analysis - MarketBeat

Voyager Therapeutics (VYGR) Stock Price, News & Analysis  MarketBeat

Voyager Therapeutics (VYGR) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Voyager Therapeutics stock soars, analysts raise price target on new collaboration with Neurocrine Biosciences to advance its gene therapies - Proactive financial news

Voyager Therapeutics stock soars, analysts raise price target on new collaboration with Neurocrine Biosciences to advance its gene therapies  Proactive financial news

Voyager Therapeutics stock soars, analysts raise price target on new collaboration with Neurocrine Biosciences to advance its gene therapies - Proactive financial news

Click here to get full coverage on Alfred W. Sandrock, Jr., M.D., Ph.D. Appointed to Voyager - GlobeNewswire

Alfred W. Sandrock, Jr., M.D., Ph.D. Appointed to Voyager  GlobeNewswire

Alfred W. Sandrock, Jr., M.D., Ph.D. Appointed to Voyager - GlobeNewswire

Click here to get full coverage on Elenium Automation launches VYGR, a USD 200m Covid recovery program to support aviation industry - Business Standard

Elenium Automation launches VYGR, a USD 200m Covid recovery program to support aviation industry  Business Standard

Elenium Automation launches VYGR, a USD 200m Covid recovery program to support aviation industry - Business Standard

Click here to get full coverage on Elenium Automation launches a USD 200m Covid recovery program, ‘VYGR’ to support aviation industry - Startup Story

Elenium Automation launches a USD 200m Covid recovery program, ‘VYGR’ to support aviation industry  Startup Story

Elenium Automation launches a USD 200m Covid recovery program, ‘VYGR’ to support aviation industry - Startup Story

Click here to get full coverage on In Voyager Digital’s messy bankruptcy, Sam Bankman-Fried holds considerable sway - Proactive financial news

In Voyager Digital’s messy bankruptcy, Sam Bankman-Fried holds considerable sway  Proactive financial news

In Voyager Digital’s messy bankruptcy, Sam Bankman-Fried holds considerable sway - Proactive financial news

Click here to get full coverage on Voyager Digital Completes Historic Token Merger - PR Newswire Canada

Voyager Digital Completes Historic Token Merger  PR Newswire Canada

Voyager Digital Completes Historic Token Merger - PR Newswire Canada

Click here to get full coverage on Celsius bankruptcy a dagger to the heart of customers - Proactive Investors

Celsius bankruptcy a dagger to the heart of customers  Proactive Investors

Celsius bankruptcy a dagger to the heart of customers - Proactive Investors

Click here to get full coverage on Voyager Digital Completes Private Placement - Business Wire

Voyager Digital Completes Private Placement  Business Wire

Voyager Digital Completes Private Placement - Business Wire

Click here to get full coverage on Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR) - Defense World

Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR)  Defense World

Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR) - Defense World

Click here to get full coverage on Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of “Buy” from Analysts  Defense World

Voyager Therapeutics Inc (VYGR)

Price Chart

Key Statistics

Technicals

About VYGR

Latest News

It's Unlikely That The CEO Of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Will See A Huge Pay Rise This Year - simplywall.st

$VYGR stock is up 24% today. Here's what we see in our data. - Nasdaq

Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers